|
|
|
|
|
|
|
|
|
|
Can Aspirin Reduce Risk for Cancer Metastasis?: Results from a report released today in a leading medical journal indicate that low dose daily aspirin reduces the risk of metastasis of several cancers. According to articles in The Lancet, the protective effect occurs within 3-5 years of beginning aspirin use.
Read more about the study in a post from our Cancer Frontline blog.
Raymond DuBois, M.D., Ph.D, MD Anderson's provost and executive vice president and a professor of cancer biology and cancer medicine, shares his insights on the study's significance and addresses questions about aspirin dose, and how cancer patients should respond to this news.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.